-
Je něco špatně v tomto záznamu ?
The Accumulation and Effects of Liposomal Doxorubicin in Tissues Treated by Radiofrequency Ablation and Irreversible Electroporation in Liver: In Vivo Experimental Study on Porcine Models
T. Andrašina, J. Jaroš, T. Jůza, T. Rohan, D. Červinka, M. Crha, V. Válek, NS. Goldberg,
Jazyk angličtina Země Spojené státy americké
Typ dokumentu časopisecké články
Grantová podpora
15-32484a
Ministerstvo Zdravotnictví Ceské Republiky
junior researcher
Masarykova Univerzita
NV15-32484A
MZ0
CEP - Centrální evidence projektů
Digitální knihovna NLK
Plný text - Článek
Zdroj
NLK
ProQuest Central
od 1997-01-01 do Před 1 rokem
Medline Complete (EBSCOhost)
od 2003-02-01 do Před 1 rokem
Nursing & Allied Health Database (ProQuest)
od 1997-01-01 do Před 1 rokem
Health & Medicine (ProQuest)
od 1997-01-01 do Před 1 rokem
- MeSH
- doxorubicin aplikace a dávkování analogy a deriváty metabolismus MeSH
- elektroporace metody MeSH
- játra chirurgie MeSH
- modely u zvířat MeSH
- polyethylenglykoly metabolismus MeSH
- prasata MeSH
- radiofrekvenční ablace metody MeSH
- zvířata MeSH
- Check Tag
- ženské pohlaví MeSH
- zvířata MeSH
- Publikační typ
- časopisecké články MeSH
PURPOSE: To compare the accumulation and effect of liposomal doxorubicin in liver tissue treated by radiofrequency ablation (RFA) and irreversible electroporation (IRE) in in vivo porcine models. MATERIALS AND METHODS: Sixteen RFA and 16 IRE procedures were performed in healthy liver of two groups of three pigs. Multi-tined RFA parameters included: 100 W, target temperature 105°C for 7 min. 100 IRE pulses were delivered using two monopolar electrodes at 2250 V, 1 Hz, for 100 µsec. For each group, two pigs received 50 mg liposomal doxorubicin (0.5 mg/kg) as a drip infusion during ablation procedure, with one pig serving as control. Samples were harvested from the central and peripheral zones of the ablation at 24 and 72 h. Immunohistochemical analysis to evaluate the degree of cellular stress, DNA damage, and degree of apoptosis was performed. These and the ablation sizes were compared. Doxorubicin concentrations were also analyzed using fluorescence photometry of homogenized tissue. RESULTS: RFA treatment zones created with concomitant administration of doxorubicin at 24 h were significantly larger than controls (2.5 ± 0.3 cm vs. 2.2 ± 0.2 cm; p = 0.04). By contrast, IRE treatment zones were negatively influenced by chemotherapy (2.2 ± 0.4 cm vs. 2.6 ± 0.4 cm; p = 0.05). At 24 h, doxorubicin concentrations in peripheral and central zones of RFA were significantly increased in comparison with untreated parenchyma (0.431 ± 0.078 µg/g and 0.314 ± 0.055 µg/g vs. 0.18 ± 0.012 µg/g; p < 0.05). Doxorubicin concentrations in IRE zones were not significantly different from untreated liver (0.191 ± 0.049 µg/g and 0.210 ± 0.049 µg/g vs. 0.18 ± 0.012 µg/g). CONCLUSIONS: Whereas there is an increased accumulation of periprocedural doxorubicin and an associated increase in ablation zone following RFA, a contrary effect is noted with IRE. These discrepant findings suggest that different mechanisms and synergies will need to be considered in order to select optimal adjuvants for different classes of ablation devices.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc19027819
- 003
- CZ-PrNML
- 005
- 20201109110412.0
- 007
- ta
- 008
- 190813s2019 xxu f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1007/s00270-019-02175-z $2 doi
- 035 __
- $a (PubMed)30761413
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxu
- 100 1_
- $a Andrašina, Tomáš $u Faculty of Medicine, Department of Radiology and Nuclear Medicine, University Hospital Brno and Masaryk University, Brno, Czech Republic.
- 245 14
- $a The Accumulation and Effects of Liposomal Doxorubicin in Tissues Treated by Radiofrequency Ablation and Irreversible Electroporation in Liver: In Vivo Experimental Study on Porcine Models / $c T. Andrašina, J. Jaroš, T. Jůza, T. Rohan, D. Červinka, M. Crha, V. Válek, NS. Goldberg,
- 520 9_
- $a PURPOSE: To compare the accumulation and effect of liposomal doxorubicin in liver tissue treated by radiofrequency ablation (RFA) and irreversible electroporation (IRE) in in vivo porcine models. MATERIALS AND METHODS: Sixteen RFA and 16 IRE procedures were performed in healthy liver of two groups of three pigs. Multi-tined RFA parameters included: 100 W, target temperature 105°C for 7 min. 100 IRE pulses were delivered using two monopolar electrodes at 2250 V, 1 Hz, for 100 µsec. For each group, two pigs received 50 mg liposomal doxorubicin (0.5 mg/kg) as a drip infusion during ablation procedure, with one pig serving as control. Samples were harvested from the central and peripheral zones of the ablation at 24 and 72 h. Immunohistochemical analysis to evaluate the degree of cellular stress, DNA damage, and degree of apoptosis was performed. These and the ablation sizes were compared. Doxorubicin concentrations were also analyzed using fluorescence photometry of homogenized tissue. RESULTS: RFA treatment zones created with concomitant administration of doxorubicin at 24 h were significantly larger than controls (2.5 ± 0.3 cm vs. 2.2 ± 0.2 cm; p = 0.04). By contrast, IRE treatment zones were negatively influenced by chemotherapy (2.2 ± 0.4 cm vs. 2.6 ± 0.4 cm; p = 0.05). At 24 h, doxorubicin concentrations in peripheral and central zones of RFA were significantly increased in comparison with untreated parenchyma (0.431 ± 0.078 µg/g and 0.314 ± 0.055 µg/g vs. 0.18 ± 0.012 µg/g; p < 0.05). Doxorubicin concentrations in IRE zones were not significantly different from untreated liver (0.191 ± 0.049 µg/g and 0.210 ± 0.049 µg/g vs. 0.18 ± 0.012 µg/g). CONCLUSIONS: Whereas there is an increased accumulation of periprocedural doxorubicin and an associated increase in ablation zone following RFA, a contrary effect is noted with IRE. These discrepant findings suggest that different mechanisms and synergies will need to be considered in order to select optimal adjuvants for different classes of ablation devices.
- 650 _2
- $a zvířata $7 D000818
- 650 _2
- $a doxorubicin $x aplikace a dávkování $x analogy a deriváty $x metabolismus $7 D004317
- 650 _2
- $a elektroporace $x metody $7 D018274
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a játra $x chirurgie $7 D008099
- 650 _2
- $a modely u zvířat $7 D023421
- 650 _2
- $a polyethylenglykoly $x metabolismus $7 D011092
- 650 _2
- $a radiofrekvenční ablace $x metody $7 D000078703
- 650 _2
- $a prasata $7 D013552
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Jaroš, Josef $u Faculty of Medicine, Department of Histology and Embryology, Masaryk University, Brno, Czech Republic.
- 700 1_
- $a Jůza, Tomáš $u Faculty of Medicine, Department of Radiology and Nuclear Medicine, University Hospital Brno and Masaryk University, Brno, Czech Republic. juza.tomas@fnbrno.cz.
- 700 1_
- $a Rohan, Tomáš $u Faculty of Medicine, Department of Radiology and Nuclear Medicine, University Hospital Brno and Masaryk University, Brno, Czech Republic.
- 700 1_
- $a Červinka, Dalibor $u Faculty of Electrical Engineering and Communication, Department of Power Electrical and Electronic Engineering, Brno University of Technology, Brno, Czech Republic.
- 700 1_
- $a Crha, Michal $u Faculty of Veterinary Medicine, Department of Surgery and Orthopedics, Small Animal Clinic, University of Veterinary and Pharmaceutical Sciences Brno, Brno, Czech Republic.
- 700 1_
- $a Válek, Vlastimil $u Faculty of Medicine, Department of Radiology and Nuclear Medicine, University Hospital Brno and Masaryk University, Brno, Czech Republic.
- 700 1_
- $a Goldberg, Nahum S $u Hadassah Hebrew University Medical Center, Jerusalem, Israel.
- 773 0_
- $w MED00001056 $t Cardiovascular and interventional radiology $x 1432-086X $g Roč. 42, č. 5 (2019), s. 751-762
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/30761413 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20190813 $b ABA008
- 991 __
- $a 20201109110412 $b ABA008
- 999 __
- $a ok $b bmc $g 1432968 $s 1066279
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2019 $b 42 $c 5 $d 751-762 $e 20190213 $i 1432-086X $m Cardiovascular and interventional radiology $n Cardiovasc Intervent Radiol $x MED00001056
- GRA __
- $a 15-32484a $p Ministerstvo Zdravotnictví Ceské Republiky
- GRA __
- $a junior researcher $p Masarykova Univerzita
- GRA __
- $a NV15-32484A $p MZ0
- LZP __
- $a Pubmed-20190813